MD - 1982
Carol Mason, M.D. is a graduate of LSU Medical School in New Orleans, LA. She completed Internal Medicine residency training at Charity Hospital in New Orleans (LSU Division), and Pulmonary/Critical Care Medicine fellowship training at the University of Texas Southwestern Medical School in Dallas, Texas. She is currently the Louis R. Cabiran Professor and Acting Chief of the Section of Pulmonary/Critical Care Medicine at LSU Medical School. She serves as the Medical Director of Respiratory Therapy at the Interim LSU Hospital (formerly Charity Hospital). Dr. Mason is a basic research investigator, examining the role of alcohol consumption on pulmonary tuberculosis in a murine model, and is collaborating in translational research to correlate human and nonhuman primate latent and active TB infection. Other interests include pulmonary infections, and the burgeoning problem of antimicrobial resistance, as well as tobacco abuse and smoking cessation.
Mechanisms of pulmonary host defense against infections
|Committees & Administrative Responsibilities||
LSUHSC SOM Committee on Professional Conduct
Porretta E, Happel KI, Teng XS, Ramsay A, Mason CM. The impact of alcohol on BCG-induced immunity against Mycobacterium tuberculosis. Alc Clin Exp Res 36:310-317, 2012
Ramirez J, Mason C, Ali J. Case of the Month: Mycobacterium avium complex pulmonary disease: management options in HIV-negative patients. Journal of the Louisiana State Medical Society, 160:248-254, 2008.
Aujla SJ, Chan YR, Zheng M, Fei M, Askew DJ, Pociask DA, Reinhart TA, McAllister F, Edeal J, Gaus K, Husain S, Kreindler JL, Dubin PJ, Pilewski JM, Myerburg MM, Mason CM, Iwakura Y, Kolls JK. IL-22 mediates mucosal host defense against gram negative bacterial pneumonia. Nat Med 14:275-281, 2008 (advance online, doi:10.1038/nm1710).
Ramirez J, Mason C, Ali J. Use of mefloquine in multi-drug resistant Mycobacterium avium complex pulmonary disease in an HIV-negative patient. Curr Ther Res 68:421-429, 2007.
Mason C, Porretta E, Zhang P, Nelson S. CD4+CD25+TGF--producing T cells are present in the lung in murine tuberculosis and may regulate the host inflammatory response. Clin Exp Immunol 148:537-545, 2007. (doi: 10.1111/j.1365-2249.2007.03371.x)
Zea AH, Culotta K, Ali J, Mason C, Park H, Zabeleta J, Garcia LF, Ochoa AC. Decreased expression of CD3 and NF-B in patients with pulmonary tuberculosis (PTB): potential mechanisms and reversibility with treatment. J Infect Dis 194:1385-1393, 2006.
Zhang P, Mason CM, Nelson S. Phagocytes in the pulmonary host defense system. In: Respiratory Infections, Torres A, Ewig S, Mandell L, and Woodhead M, eds. Hodder Arnold Publishers, London, 2006; pp 19-29.
Seoane L and Mason CM. Parenchymal Lung Disease. In: Pulmonary Pathophysiology, 2nd ed. Ali J, Levitzky MG, and Summer WR, eds. McGraw-Hill, New York, 2005; pp 105-125.
Happel KI, Lockhart E, Mason CM, Porretta E, Keoshkerian E, Odden AR, Nelson S, Ramsay AJ. Pulmonary IL-23 gene delivery increases local T cell immunity and controls growth of Mycobacterium tuberculosis in the lungs. Infect Immun 73:5782, 2005.
Badewa AP, Quinton LJ, Shellito JE, and Mason CM. Chemokine receptor 5 and its ligands in the immune response to murine tuberculosis. Tuberculosis 85:185-195, 2005.